tiprankstipranks

Cambridge Cognition’s CANTAB Platform Validated in Major Brain Health Study

Story Highlights
  • Cambridge Cognition specializes in digital brain health products, enhancing clinical research and treatment.
  • The Intuition study validates CANTAB’s scalability and sensitivity, boosting Cambridge Cognition’s market position.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cambridge Cognition’s CANTAB Platform Validated in Major Brain Health Study

Confident Investing Starts Here:

The latest update is out from Cambridge Cognition Holdings ( (GB:COG) ).

Cambridge Cognition has announced its involvement in the Intuition Brain Health study, one of the largest brain health studies ever conducted, which demonstrates the value of its CANTAB digital cognitive assessments. The study, published in Nature Medicine and sponsored by Biogen in collaboration with Apple, enrolled 23,004 participants and highlighted the scalability and sensitivity of Cambridge Cognition’s platform for remote cognitive evaluation. This positions the company as a leader in digital brain health solutions, with significant market opportunities for real-world brain health monitoring applications.

More about Cambridge Cognition Holdings

Cambridge Cognition is a brain health software group specializing in digital health products that advance brain health research and treatment. The company offers four core products: CANTAB assessments, a flexible eCOA platform, rater training services, and quality assurance tools. These products collectively improve clinical trial outcomes, enable early patient identification, and enhance global efficiency in healthcare and pharmaceuticals.

YTD Price Performance: 13.33%

Average Trading Volume: 60,776

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £17.79M

See more insights into COG stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App